HGF and metabolic dysfunction-associated steatotic liver disease: Although there is a report with the application using HGF gene therapy on a rat model of NAFLD-fibrosis (15), to the best of our knowledge, the therapeutic effect of recombinant HGF protein on the development of NASH has not been reported.